{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:48:38Z","timestamp":1792244918087,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11102-026-01662-0","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:48:52Z","timestamp":1777513732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Decision-making and impulsivity in cabergoline-treated prolactinoma: findings from Iowa Gambling, Go\/No-Go, and barratt scales"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6287-7655","authenticated-orcid":false,"given":"P\u00fcren","family":"G\u00f6kbulut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3134-6322","authenticated-orcid":false,"given":"H\u00fcseyin","family":"Nergiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice Ceren","family":"T\u0131r\u0131\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1390-7571","authenticated-orcid":false,"given":"I\u015f\u0131lay","family":"Ta\u015fkald\u0131ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7906-2479","authenticated-orcid":false,"given":"Volkan","family":"G\u00f6kbulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2602-1657","authenticated-orcid":false,"given":"\u015eerife Mehlika","family":"Ku\u015fkonmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"2","key":"1662_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s11102-013-0480-6","volume":"17","author":"M Barake","year":"2014","unstructured":"Barake M, Evins AE, Stoeckel L, Pachas GN, Nachtigall LB, Miller KK, Biller BM, Tritos NA, Klibanski A (2014) Investigation of impulsivity in patients on dopamineagonisttherapyforhyperprolactinemia: a pilot study. Pituitary 17(2):150\u20136. https:\/\/doi.org\/10.1007\/s11102-013-0480-6","journal-title":"Pituitary"},{"key":"1662_CR2","doi-asserted-by":"publisher","unstructured":"De Sousa SMC, Baranoff J, Rushworth RL, Butler J, Sorbello J, Vorster J, Thompson T, McCormack AI, Inder WJ, Torpy DJ (2020) Impulse control disorders in dopamineagonist-treatedhyperprolactinemia: prevalenceand risk factors. J Clin Endocrinol Metab 105(3):dgz076. https:\/\/doi.org\/10.1210\/clinem\/dgz076. PMID: 31580439","DOI":"10.1210\/clinem\/dgz076"},{"issue":"1","key":"1662_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-022-01009-3","volume":"22","author":"X Ke","year":"2022","unstructured":"Ke X, Wang L, Chen M, Liu S, Yu N, Duan L, Gong F, Zhu H (2022) Thesideeffects of dopaminereceptoragonistdrugs in chineseprolactinomapatients: a crosssectionalstudy. BMC Endocr Disord 22(1):97. https:\/\/doi.org\/10.1186\/s12902-022-01009-3","journal-title":"BMC Endocr Disord"},{"issue":"6","key":"1662_CR4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39869","volume":"15","author":"M Calva-Gonz\u00e1lez","year":"2023","unstructured":"Calva-Gonz\u00e1lez M, Villanueva-Sol\u00f3rzano PL, Crail-Mel\u00e9ndez ED, Loya-Murguia KM, DehesaHernandez IA, Robles-Ramirez F, Rodr\u00edguez-Hern\u00e1ndez LA, Mondrag\u00f3n-Soto MG, Flores-V\u00e1zquez JG, Portocarrero-Ortiz LA (2023) Neuropsychiatriceffects in patientswithinvasiveprolactinomastreatedwithcabergoline. Cureus 15(6):e39869. https:\/\/doi.org\/10.7759\/cureus.39869","journal-title":"Cureus"},{"issue":"3","key":"1662_CR5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s12020-018-1744-8","volume":"62","author":"E Celik","year":"2018","unstructured":"Celik E, Ozkaya HM, Poyraz BC, Saglam T, Kadioglu P (2018) Impulse control disorders in patientswithprolactinomareceivingdopamineagonisttherapy: a prospective study with 1 year follow-up. Endocrine 62(3):692\u2013700. https:\/\/doi.org\/10.1007\/s12020-018-1744-8","journal-title":"Endocrine"},{"key":"1662_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2025.111363","volume":"138","author":"P Penchev","year":"2025","unstructured":"Penchev P, Milanova-Ilieva D, Gaydarski L, Husain N, Chenkov Y, Petrov PP, Kirovakov Z, Stanchev P (2025) Impulsecontroldisorders in prolactinomapatientstreatedwithdopamineagonists: a systematicreviewand meta-analysiswithtrialsequentialanalysis. J Clin Neurosci 138:111363. https:\/\/doi.org\/10.1016\/j.jocn.2025.111363","journal-title":"J Clin Neurosci"},{"key":"1662_CR7","volume-title":"Diagnosticand Statistical Manual of MentalDisorders","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association (2000) Diagnosticand Statistical Manual of MentalDisorders, 4th edition, textrev. AmericanPsychiatricAssociation, Washington, DC","edition":"4th edition, te"},{"issue":"5","key":"1662_CR8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s11154-022-09753-6","volume":"23","author":"A Hamidianjahromi","year":"2022","unstructured":"Hamidianjahromi A, Tritos NA (2022) Impulsecontroldisorders in hyperprolactinemicpatients on dopamineagonisttherapy. Rev Endocr Metab Disord 23(5):1089\u20131099. https:\/\/doi.org\/10.1007\/s11154-022-09753-6","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"1662_CR9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/cen.12375","volume":"80","author":"I Bancos","year":"2014","unstructured":"Bancos I, Nannenga MR, Bostwick JM, Silber MH, Erickson D, Nippoldt TB (2014) Impulsecontroldisorders in patientswithdopamineagonist-treatedprolactinomasandnonfunctioningpituitaryadenomas: a case-controlstudy. ClinEndocrinol (Oxf) 80(6):863\u20138. https:\/\/doi.org\/10.1111\/cen.12375","journal-title":"ClinEndocrinol (Oxf)"},{"issue":"2","key":"1662_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-025-01533-0","volume":"28","author":"P Kadioglu","year":"2025","unstructured":"Kadioglu P, Glezer A (2025) Impulse control disorders in pituitary adenoma: what do we know and what we still don\u2019t know in almost two decades? Pituitary 28(2):71. https:\/\/doi.org\/10.1007\/s11102-025-01533-0","journal-title":"Pituitary"},{"issue":"17","key":"1662_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/nrn.2017.8","volume":"18","author":"JW Dalley","year":"2017","unstructured":"Dalley JW, Robbins TW (2017) Fractionating impulsivity: neuropsychiatric implications. Nat Rev Neurosci 18(17):158\u2013171. https:\/\/doi.org\/10.1038\/nrn.2017.8","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"1662_CR12","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/WCO.0b013e3283489687","volume":"24","author":"V Voon","year":"2011","unstructured":"Voon V, Mehta AR, Hallett M (2011) Impulse control disorders in Parkinson\u2019s disease: recent advances. Curr Opin Neurol 24(4):324\u201330. https:\/\/doi.org\/10.1097\/WCO.0b013e3283489687","journal-title":"Curr Opin Neurol"},{"key":"1662_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.579606","volume":"11","author":"JM Hinojosa-Amaya","year":"2020","unstructured":"Hinojosa-Amaya JM, Johnson N, Gonz\u00e1lez-Torres C, Varlamov EV, Yedinak CG, McCartney S, Fleseriu M (2020) Depression and impulsivity self-assessment tools to identify dopamine agonist side effects in patients with pituitary adenomas. Front Endocrinol (Lausanne) 11:579606. https:\/\/doi.org\/10.3389\/fendo.2020.579606","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"1662_CR14","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::aid-jclp2270510607>3.0.co;2-1","volume":"51","author":"JH Patton","year":"1995","unstructured":"Patton JH, Stanford MS, Barratt ES (1995) Factor structure of the Barratt impulsiveness scale. J Clin Psychol 51(6):768\u201374. https:\/\/doi.org\/10.1002\/1097-4679(199511)51:6%3C;768::aid-jclp2270510607%3E;3.0.co;2-1","journal-title":"J Clin Psychol"},{"issue":"2","key":"1662_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4274\/npa.y6296","volume":"50","author":"L Tamam","year":"2013","unstructured":"Tamam L, G\u00fcle\u00e7 H, Karata\u015f G (2013) Short form of BIS-11 SF(BIS-11 SF-11-SF) Turkish adaptation study. Arch Neuropsychiatr 50(2):130","journal-title":"Arch Neuropsychiatr"},{"issue":"1\u20133","key":"1662_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0010-0277(94)90018-3","volume":"50","author":"A Bechara","year":"1994","unstructured":"Bechara A, Damasio AR, Damasio H, Anderson SW (1994) Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 50(1\u20133):7\u201315. https:\/\/doi.org\/10.1016\/0010-0277(94)90018-3","journal-title":"Cognition"},{"issue":"1","key":"1662_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bandc.2004.08.015","volume":"57","author":"CH Bowman","year":"2005","unstructured":"Bowman CH, Evans CE, Turnbull OH (2005) Artificial time constraints on the Iowa Gambling Task: the effects on behavioural performance and subjective experience. Brain Cogn 57(1):21\u20135. https:\/\/doi.org\/10.1016\/j.bandc.2004.08.015","journal-title":"Brain Cogn"},{"issue":"1\u20132","key":"1662_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jneumeth.2006.11.017","volume":"162","author":"JW Peirce","year":"2007","unstructured":"Peirce JW (2007) PsychoPy\u2013psychophysics software in Python. J Neurosci Methods 162(1\u20132):8\u201313. https:\/\/doi.org\/10.1016\/j.jneumeth.2006.11.017","journal-title":"J Neurosci Methods"},{"issue":"1","key":"1662_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0093-934x(82)90053-0","volume":"15","author":"B Gordon","year":"1982","unstructured":"Gordon B, Caramazza A (1982) Lexical decision for open- and closed-class words: failure to replicate differential frequency sensitivity. Brain Lang 15(1):143\u201360. https:\/\/doi.org\/10.1016\/0093-934x(82)90053-0","journal-title":"Brain Lang"},{"key":"1662_CR20","unstructured":"Karaka\u015f S (2017) Psychology dictionary [Dictionary of psychology]. Nobel Publishing"},{"key":"1662_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2020.101356","volume":"55","author":"HM Ozkaya","year":"2020","unstructured":"Ozkaya HM, Sahin S, Korkmaz OP, Durcan E, Sahin HR, Celik E, Poyraz BC, Kadioglu P (2020) Patients with acromegaly might not be at higher risk for dopamine agonist-induced impulse control disorders than those with prolactinomas. Growth Horm IGF Res 55:101356. https:\/\/doi.org\/10.1016\/j.ghir.2020.101356","journal-title":"Growth Horm IGF Res"},{"issue":"8","key":"1662_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2023.102910","volume":"54","author":"R Hamblin","year":"2023","unstructured":"Hamblin R, Karavitaki N (2023) Impulse control disorders in patients with pituitary tumors treated with dopamine agonists: a systematic review. Arch Med Res 54(8):102910. https:\/\/doi.org\/10.1016\/j.arcmed.2023.102910","journal-title":"Arch Med Res"},{"issue":"4","key":"1662_CR23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.58516","volume":"16","author":"MM Mohammad","year":"2024","unstructured":"Mohammad MM, Alidrisi HA, Mansour AA (2024) Impulse control disorders in Southern Iraqi patients medicated with cabergoline for prolactinoma. Cureus 16(4):e58516. https:\/\/doi.org\/10.7759\/cureus.58516","journal-title":"Cureus"},{"key":"1662_CR24","doi-asserted-by":"publisher","unstructured":"Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AF (2007) Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci. ;10(3):376\u2009\u2013\u200984. https:\/\/doi.org\/10.1038\/nn1846. Epub 2007 Feb 4. PMID: 17277774","DOI":"10.1038\/nn1846"},{"issue":"1","key":"1662_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40264-017-0590-6","volume":"41","author":"M Grall-Bronnec","year":"2018","unstructured":"Grall-Bronnec M, Victorri-Vigneau C, Donnio Y, Leboucher J, Rousselet M, Thiabaud E, Zreika N, Derkinderen P, Challet-Bouju G (2018) Dopamine agonists and impulse control disorders: a complex association. Drug Saf 41(1):19\u201375. https:\/\/doi.org\/10.1007\/s40264-017-0590-6","journal-title":"Drug Saf"},{"issue":"8","key":"1662_CR26","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s40618-020-01478-0","volume":"44","author":"G Beccuti","year":"2021","unstructured":"Beccuti G, Guaraldi F, Natta G, Cambria V, Prencipe N, Cicolin A, Montanaro E, Lopiano L, Ghigo E, Zibetti M, Grottoli S (2021) Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study. J Endocrinol Invest 44(8):1699\u20131706. https:\/\/doi.org\/10.1007\/s40618-020-01478-0","journal-title":"J Endocrinol Invest"},{"key":"1662_CR27","doi-asserted-by":"publisher","unstructured":"Dogansen SC, Cikrikcili U, Oruk G, Kutbay NO, Tanrikulu S, Hekimsoy Z, Hadzalic A, Gorar S, Omma T, Mert M, Akbaba G, Yalin GY, Bayram F, Ozkan M, Yarman S (2019) Dopamine agonist-induced impulse control disorders in patients with prolactinoma: a cross-sectional multicenter study. J Clin Endocrinol Metab 104(7):2527\u20132534. https:\/\/doi.org\/10.1210\/jc.2018-02202. PMID: 30848825","DOI":"10.1210\/jc.2018-02202"},{"issue":"2","key":"1662_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12020-015-0727-2","volume":"51","author":"S Noronha","year":"2016","unstructured":"Noronha S, Stokes V, Karavitaki N, Grossman A (2016) Treating prolactinomas with dopamine agonists: always worth the gamble? Endocrine 51(2):205\u201310. https:\/\/doi.org\/10.1007\/s12020-015-0727-2","journal-title":"Endocrine"},{"issue":"3","key":"1662_CR29","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1007\/s00415-021-10724-1","volume":"269","author":"L - Cao","year":"2022","unstructured":"- Cao L, Xu T, Zhao G, Lv D, Lu J, Zhao G (2022) Risk factors of impulsive-compulsive behaviors in PD patients: a meta-analysis. J Neurol 269(3):1298\u20131315. https:\/\/doi.org\/10.1007\/s00415-021-10724-1Epub 2021 Aug 9. PMID: 34370054","journal-title":"J Neurol"},{"issue":"1","key":"1662_CR30","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1530\/EO-21-0038","volume":"2","author":"SMC De Sousa","year":"2022","unstructured":"De Sousa SMC (2022) Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management? Endocr Oncol 2(1):R31\u2013R50. https:\/\/doi.org\/10.1530\/EO-21-0038PMID: 37435462; PMCID: PMC10259306","journal-title":"Endocr Oncol"},{"key":"1662_CR31","doi-asserted-by":"publisher","unstructured":"Sahin S, Sudutan T, Kavla Y, Durcan E, \u00d6zogul YY, Poyraz BC, Sayitoglu M, Ozkaya HM, Kadioglu P (2023) A genetic assessment of dopamine agonist-induced impulse control disorder in patients with prolactinoma. J Clin Endocrinol Metab 108(6):e275-e282. https:\/\/doi.org\/10.1210\/clinem\/dgac718. PMID: 36494095","DOI":"10.1210\/clinem\/dgac718"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01662-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01662-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01662-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:49:28Z","timestamp":1782409768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-026-01662-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1662"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01662-0","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}